Influence of hepatitis C virus eradication with direct ‐acting antivirals on the gut microbiota in patients with cirrhosis
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 22, 2018 Category: Drugs & Pharmacology Authors: Francesca Romana Ponziani, Lorenza Putignani, Francesco Paroni Sterbini, Valentina Petito, Anna Picca, Federica Del Chierico, Sofia Reddel, Riccardo Calvani, Emanuele Marzetti, Maurizio Sanguinetti, Antonio Gasbarrini, Maurizio Pompili Source Type: research

Persistent damage on magnetic resonance enterography in patients with Crohn ’s disease in endoscopic remission
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 22, 2018 Category: Drugs & Pharmacology Authors: Jordi Rimola, Ignacio Alfaro, Agn ès Fernández‐Clotet, Jesús Castro‐Poceiro, Daniel Vas, Sonia Rodríguez, Maria Carme Masamunt, Ingrid Ordás, Elena Ricart, Julián Panés Source Type: research

Long ‐term prognostic value of the FibroTest in patients with non‐alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 18, 2018 Category: Drugs & Pharmacology Authors: Mona Munteanu, Raluca Pais, Valentina Peta, Olivier Deckmyn, Joseph Moussalli, Yen Ngo, Marika Rudler, Pascal Lebray, Frederic Charlotte, Vincent Thibault, Olivier Lucidarme, An Ngo, Fran çoise Imbert‐Bismut, Chantal Housset, Dominique Th Source Type: research

Retraction: Randomised clinical trial: The clinical efficacy and safety of an alginate ‐antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China by J. Sun, C. Yang, H. Zhao, P. Zheng, J. Wilkinson, B. Ng, Y. Yuan. Aliment Pharmacol Ther. 2015;42:845‐854.
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1039-1039, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Source Type: research

Issue Information
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 889-891, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Source Type: research

Editorial: predicting hepatic encephalopathy after TIPSS —is multimodal cerebral MRI the answer?
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1019-1020, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Matthew J. Armstrong, Dhiraj Tripathi Source Type: research

Editorial: severe outcomes are rare in pregnancy with autoimmune hepatitis
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1017-1018, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Hannes Hagstrom, Jonas F. Ludvigsson Source Type: research

Editorial: hepatocellular carcinoma in non ‐cirrhotic NASH—a troubling reality
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1021-1023, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Marie Boyle, Quentin M. Anstee Source Type: research

Editorial: predicting hepatic encephalopathy after TIPSS —is multimodal cerebral MRI the answer? Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1020-1021, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Marika Rudler, Damien Galanaud, Dominique Thabut Source Type: research

Editorial: severe outcomes are rare in pregnancy in autoimmune hepatitis —Authors' reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1018-1019, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Lisbet Gr ønbæk, Hendrik Vilstrup, Peter Jepsen Source Type: research

Letter: microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1026-1026, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Yao ‐Ming Zhang, Zhen‐Tao Zhou, Gao‐Min Liu Source Type: research

Letter: long ‐term treatment of severe bile acid diarrhoea—obeticholic acid can normalise SeHCAT retention
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1032-1034, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Julian R. F. Walters Source Type: research

Letter: acute liver failure of indeterminate aetiology
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1024-1025, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Keiichi Fujiwara, Shin Yasui, Osamu Yokosuka, Naoya Kato Source Type: research

Letter: which risk factors for post ‐operative recurrence in Crohn's disease can be modified?
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1031-1032, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Nicola Imperatore, Antonio Rispo, Gaetano Luglio, Luigi Bucci, Fabiana Castiglione Source Type: research

Letter: can a specific surgical approach reduce post ‐operative recurrence in Crohn's disease?
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1030-1031, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Takayuki Yamamoto, Paulo Gustavo Kotze Source Type: research

Letter: microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria —Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1027-1028, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Wenwu Liu, Binkui Li, Yunfei Yuan Source Type: research

Letter: the association between the use of different proton pump inhibitors and microscopic colitis should be re ‐evaluated
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1035-1035, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Ping Tao, Shiying Wang Source Type: research

Letter: is there a role for infliximab biosimilar in patients with inflammatory bowel disease with secondary loss of response to infliximab innovator?
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1037-1038, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Eleni Orfanoudaki, Ioannis Drygiannakis, Ioannis E. Koutroubakis Source Type: research

Letter: long ‐term treatment of severe bile acid diarrhoea—obeticholic acid can normalise SeHCAT retention. Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1034-1035, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Brian Damsgaard, Helene R. Dalby, Klaus Krogh, Simon M. D. J ørgensen, Anne Kirstine Arveschough, Jørgen Agnholt, Jens Frederik Dahlerup, Søren Peter Jørgensen Source Type: research

Letter: the association between the use of different proton pump inhibitors and microscopic colitis should be re ‐evaluated—author's reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1036-1036, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Ole K. Bonderup Source Type: research

Letter: acute liver failure of indeterminate aetiology —Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1025-1026, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Paul N. Brennan, Mhairi C. Donnelly, Kenneth J. Simpson Source Type: research

Letter: overcoming secondary loss of response to infliximab —it is not the drug, it is how you use it! Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1029-1030, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Erwin Dreesen, Ann Gils Source Type: research

Letter: overcoming secondary loss of response to infliximab —it is not the drug, it is how you use it!
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 9, Page 1028-1029, November 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 15, 2018 Category: Drugs & Pharmacology Authors: Daniel R. Langenberg, Abhinav Vasudevan Source Type: research

Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti ‐viral therapy in patients with chronic hepatitis B
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 11, 2018 Category: Drugs & Pharmacology Authors: Yao ‐Chun Hsu, Tomi Jun, Yen‐Tsung Huang, Ming‐Lun Yeh, Chia‐Long Lee, Shintaro Ogawa, Shu‐Hsien Cho, Jaw‐Town Lin, Ming‐Lung Yu, Mindie H. Nguyen, Yasuhito Tanaka Source Type: research

Randomised clinical trial: reducing the intake of dietary FODMAPs of breastfeeding mothers is associated with a greater improvement of the symptoms of infantile colic than for a typical diet
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 11, 2018 Category: Drugs & Pharmacology Authors: Marina Iacovou, Simon S. Craig, Greg W. Yelland, Jacqueline S. Barrett, Peter R. Gibson, Jane G. Muir Source Type: research

Systematic review with meta ‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 8, 2018 Category: Drugs & Pharmacology Authors: Alexander C. Ford, Lucinda A. Harris, Brian E. Lacy, Eamonn M.  M. Quigley, Paul Moayyedi Source Type: research

Microbial translocation and T cell activation are modified by direct ‐acting antiviral therapy in HCV‐infected patients
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 8, 2018 Category: Drugs & Pharmacology Authors: Barbara Lattanzi, Silvia Baroncelli, Adriano De Santis, Clementina Maria Galluzzo, Gianluca Mennini, Zuleika Michelini, Marinella Lupo, Stefano Ginanni Corradini, Massimo Rossi, Lucia Palmisano, Manuela Merli Source Type: research

The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 8, 2018 Category: Drugs & Pharmacology Authors: Thomas P. C. Chu, Matthew J. Grainge, Timothy R. Card Source Type: research

Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non ‐erosive reflux disease
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 8, 2018 Category: Drugs & Pharmacology Authors: Mentore Ribolsi, Michele Cicala, Patrizia Zentilin, Matteo Neri, Aurelio Mauro, Konstantinos Efthymakis, Tommasangelo Petitti, Vincenzo Savarino, Roberto Penagini Source Type: research

Review article: novel antivirals for hepatitis C —sofosbuvir/velpatasvir/voxilaprevir, glecaprevir/pibrentasvir
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 5, 2018 Category: Drugs & Pharmacology Authors: Brian L. Pearlman, Andrew E. Hinds Source Type: research

Predictors of advanced fibrosis in non ‐cirrhotic non‐alcoholic fatty liver disease in Germany
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 5, 2018 Category: Drugs & Pharmacology Authors: Christian Labenz, Yvonne Huber, Eva Kalliga, Michael Nagel, Christian Ruckes, Beate K. Straub, Peter R. Galle, Marcus ‐Alexander Wörns, Quentin M. Anstee, Detlef Schuppan, Jörn M. Schattenberg Source Type: research

Anxiety after coeliac disease diagnosis predicts mucosal healing: a population ‐based study
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 5, 2018 Category: Drugs & Pharmacology Authors: Jonas F. Ludvigsson, Benjamin Lebwohl, Qi Chen, Gabriella Br öms, Randi L. Wolf, Peter H. R. Green, Louise Emilsson Source Type: research

Issue Information
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 8, Page 777-779, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 3, 2018 Category: Drugs & Pharmacology Source Type: research

Editorial: a baseline tool for predicting response to peginterferon alfa ‐2a in HBeAg‐positive patients—same score, different outcomes. Author's Reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 8, Page 876-877, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 3, 2018 Category: Drugs & Pharmacology Authors: Henry Lik Yuen Chan Source Type: research

Editorial: clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long ‐term analogue therapy for HBV
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 8, Page 879-880, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 3, 2018 Category: Drugs & Pharmacology Authors: Leanne Stratton, Andrew Bathgate Source Type: research

Editorial: a baseline tool for predicting response to peginterferon alfa ‐2a in HBeAg‐positive patients—same score, different outcomes
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 8, Page 875-876, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 3, 2018 Category: Drugs & Pharmacology Authors: Cheng ‐Yuan Peng Source Type: research

Editorial: less acid, less cancer? Is this the question? Authors ’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 8, Page 878-879, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 3, 2018 Category: Drugs & Pharmacology Authors: Mimi C. Tan, Aaron P. Thrift Source Type: research

Editorial: less acid, less cancer? Is this the question?
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 8, Page 877-878, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 3, 2018 Category: Drugs & Pharmacology Authors: George Triadafilopoulos, Gurkirpal Singh Source Type: research

Editorial: proton pump inhibitors (PPIs) and microscopic colitis
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 8, Page 880-881, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 3, 2018 Category: Drugs & Pharmacology Authors: Robin Krol, Martijn G. H. Oijen Source Type: research

Letter: screening for adrenal suppression in paediatric inflammatory bowel disease
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 8, Page 884-885, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 3, 2018 Category: Drugs & Pharmacology Authors: P. Wood, P. Henderson Source Type: research

Letter: identifying coeliac disease among patients with bloating
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 8, Page 882-883, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 3, 2018 Category: Drugs & Pharmacology Authors: P. Ellul, C. Zammit Source Type: research

Letter: identifying coeliac disease among patients with bloating —Authors' reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 8, Page 883-883, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 3, 2018 Category: Drugs & Pharmacology Authors: Isabel A. Hujoel, Alberto Rubio ‐Tapia Source Type: research

Letter: proton pump inhibitors use and risk of hepatocellular carcinoma: A meta ‐analysis of observational studies
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 8, Page 886-888, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 3, 2018 Category: Drugs & Pharmacology Authors: Jian Zhao, Li Hua, Na Li, Ran An, Chun Liang Source Type: research

Letter: screening for adrenal suppression in paediatric inflammatory bowel disease – authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 8, Page 885-886, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 3, 2018 Category: Drugs & Pharmacology Authors: Hamish Philpott, Michael K. Dougherty, Evan S. Dellon Source Type: research

Short and long ‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 8, Page 839-851, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - October 3, 2018 Category: Drugs & Pharmacology Authors: Mar ía Chaparro, Ana Garre, Elena Ricart, Marisa Iborra, Francisco Mesonero, Isabel Vera, Sabino Riestra, Valle García‐Sánchez, M. Luisa De Castro, Albert Martin‐Cardona, Xavier Aldeguer, Miguel Mínguez, Manuel Barreiro de‐Acosta, M Source Type: research

Issue Information
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 7, Page 693-695, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - September 24, 2018 Category: Drugs & Pharmacology Source Type: research

Editorial: interferon ‐free DAAs are a great boon for patients with hepatitis C and cryoglobulinaemia
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 7, Page 770-771, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - September 24, 2018 Category: Drugs & Pharmacology Authors: M. Atsukawa, A. Tsubota Source Type: research

Editorial: STAT ‐4 polymorphism ‐ a tool to personalise clinical practice in chronic HBV infection. Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 7, Page 769-770, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - September 24, 2018 Category: Drugs & Pharmacology Authors: Rasha El Sharkawy, Jacob George, Mohammed Eslam Source Type: research

Editorial: STAT ‐4 polymorphism ‐ a tool to personalise clinical practice in chronic HBV infection
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 7, Page 768-769, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - September 24, 2018 Category: Drugs & Pharmacology Authors: Martin Bonacci, Sabela Lens Source Type: research

Editorial: surviving your genes —the role of PNPLA3 variation in end‐stage liver disease
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 7, Page 773-775, October 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - September 24, 2018 Category: Drugs & Pharmacology Authors: C. J. Pirola, S. Sookoian Source Type: research